Biosimilars: Analytics & Market – An Article by VelaLabs
Insight into Biosimilars: Short Description, Analytical Assessment and MarketVienna, Austria, )
The review gives a short but comprehensive overview about selected biosimilars. Further, Adalimumab is analyzed in more detail, including a competitive field and the portfolio of methods required for analytical assessment. Markets not only in developed and highly regulated countries, but also in other regions are discussed.
Please find the full article here.